BioVaxys Technology Corp.
BIOV
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.90K | 3.10K | 108.80K | 152.00K | 355.30K |
| Total Receivables | 351.80K | 340.30K | 323.50K | 312.80K | 272.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 647.20K | 452.80K | 453.10K | 468.60K | 113.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.00M | 796.30K | 885.30K | 933.50K | 741.30K |
|
|
|||||
| Total Current Assets | 1.00M | 796.30K | 885.30K | 933.50K | 741.30K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | 1.00M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.00M | 796.30K | 885.30K | 933.50K | 1.74M |
|
|
|||||
| Total Accounts Payable | 1.79M | 1.10M | 1.04M | 1.12M | 1.09M |
| Total Accrued Expenses | 1.75M | 1.57M | 124.20K | 1.15M | 771.00K |
| Short-term Debt | 96.60K | 96.80K | 46.80K | 48.90K | 58.80K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 882.40K | -- | -- |
| Total Other Current Liabilities | -- | -- | 882.40K | -- | -- |
| Total Current Liabilities | 3.63M | 2.77M | 2.09M | 2.31M | 1.92M |
|
|
|||||
| Total Current Liabilities | 3.63M | 2.77M | 2.09M | 2.31M | 1.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 96.60K | 96.80K | 46.80K | 48.90K | 58.80K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.63M | 2.77M | 2.09M | 2.31M | 1.92M |
|
|
|||||
| Common Stock & APIC | 20.66M | 20.69M | 19.53M | 19.41M | 18.91M |
| Retained Earnings | -24.96M | -24.34M | -22.33M | -22.43M | -20.64M |
| Treasury Stock & Other | 1.67M | 1.68M | 1.60M | 1.64M | 1.55M |
| Total Common Equity | -2.63M | -1.98M | -1.20M | -1.38M | -180.40K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.63M | -1.98M | -1.20M | -1.38M | -180.40K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.63M | -1.98M | -1.20M | -1.38M | -180.40K |
|
|
|||||